I think the big mistake here is assuming the AAIC presentation is about Anavex. I believe this was more about Ariana, especially since Mohammed Afshar was the main presenter. The presentation is more a capabilty of what KEM analysis can weed out, and allow researchers to focus on. Anavex happens to be a strong partner and their data makes for good analysis. I'm not convinced theres much more to this than that. Gut microbia makes for possible biomarker.
Market Data 
Markets 
AI
